D
PharmaCorp Rx Inc. PCRX.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -281.00K -429.90K -757.30K -1.46M -819.70K
Total Depreciation and Amortization 459.30K 339.40K 208.80K 72.00K 16.40K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 89.70K 99.70K 113.80K 540.50K 3.00K
Change in Net Operating Assets 12.00K 290.90K 504.10K -93.80K 271.10K
Cash from Operations 280.10K 300.10K 69.40K -939.90K -529.20K
Capital Expenditure -1.55M -23.70K -5.00K -5.00K -5.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -12.88M -12.08M -12.08M -1.47M 58.60K
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -14.43M -12.10M -12.09M -1.47M 53.60K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -193.00K -157.80K -107.10K -56.00K -15.30K
Issuance of Common Stock 7.64M 27.49M 27.49M 27.49M 19.86M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 5.46M 20.00M 20.03M 20.07M 14.50M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -8.69M 8.19M 8.02M 17.65M 14.02M